1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014

Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014" provides data on the Opioid Induced Bowel Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Opioid Induced Bowel Dysfunction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Opioid Induced Bowel Dysfunction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Opioid Induced Bowel Dysfunction Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Opioid Induced Bowel Dysfunction 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Opioid Induced Bowel Dysfunction to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Opioid Induced Bowel Dysfunction to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Opioid Induced Bowel Dysfunction 28
May 21, 2012: Sucampo Presents Positive Phase III Trial Results Of Lubiprostone In Opioid-Induced Bowel Dysfunction At DDW 2012 28
Feb 06, 2012: Phynova Announces Preliminary Melokinex Phase II Clinical Trial Results 28
Feb 02, 2012: Sucampo's Lubiprostone Meets Primary Endpoint in Phase III Clinical Trial for Opioid-Induced Bowel Dysfunction 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Cubist Pharmaceuticals, Inc. 31
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 31
Salix Pharmaceuticals Ltd. 32
Clinical Trial Overview of Salix Pharmaceuticals Ltd. 32
Sucampo Pharmaceuticals, Inc. 33
Clinical Trial Overview of Sucampo Pharmaceuticals, Inc. 33
Shionogi and Co., Ltd. 34
Clinical Trial Overview of Shionogi and Co., Ltd. 34
Helsinn Holding S.A. 35
Clinical Trial Overview of Helsinn Holding S.A. 35
Clinical Trial Overview of Top Institutes / Government 36
Yokohama City University Hospital 36
Clinical Trial Overview of Yokohama City University Hospital 36
Mech-Sense 37
Clinical Trial Overview of Mech-Sense 37
Kuopio University Hospital 38
Clinical Trial Overview of Kuopio University Hospital 38
Five Key Clinical Profiles 39
Appendix 135
Abbreviations 135
Definitions 135
Research Methodology 136
Secondary Research 136
About GlobalData 137
Contact Us 137
Disclaimer 137
Source 138

List of Tables
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials by Region, 2014* 6
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Opioid Induced Bowel Dysfunction to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Opioid Induced Bowel Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Opioid Induced Bowel Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Opioid Induced Bowel Dysfunction to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Opioid Induced Bowel Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Opioid Induced Bowel Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 30
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014* 31
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals Ltd., 2014* 32
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Sucampo Pharmaceuticals, Inc., 2014* 33
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi and Co., Ltd., 2014* 34
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinn Holding S.A., 2014* 35
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University Hospital, 2014* 36
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Mech-Sense, 2014* 37
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2014* 38

List of Figures
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Opioid Induced Bowel Dysfunction to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Opioid Induced Bowel Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Opioid Induced Bowel Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Opioid Induced Bowel Dysfunction to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Opioid Induced Bowel Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Opioid Induced Bowel Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Opioid Induced Bowel Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Opioid Induced Bowel Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 27
GlobalData Methodology 136

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
North America Opioid Market Analysis By Product, By Application And Segment Forecasts To 2024

North America Opioid Market Analysis By Product, By Application And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The North America opioid market is expected to reach USD 18.5 billion by 2024, according to a new report by Grand View Research, Inc. Favorable regulations and healthcare reforms are providing an environment, ...

Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period

Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period

  • $ 4900
  • Industry report
  • August 2016
  • by Persistence Market Research

Opioids are naturally occurring opiates and synthetic and semi-synthetic drugs that act on opioid receptors in the brain and can cause dependence due to their euphoric effects. Opioids are majorly categorized ...

PAIN MANAGEMENT- NEW DISCOVERIES AND TREATMENT OPTIONS IN ABUSE DETERRENT ERA

PAIN MANAGEMENT- NEW DISCOVERIES AND TREATMENT OPTIONS IN ABUSE DETERRENT ERA

  • $ 3080
  • Industry report
  • September 2016
  • by MP Advisors

Rescheduling of Hydrocodone combinations from Class III to Class II, clear-cut regulatory guideline for Abuse Deterrent drug formulation NDA & ANDA (solid oral) filing and CDC guideline for Prescribing ...


Download Unlimited Documents from Trusted Public Sources

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Therapy Market in the UK

  • December 2016
    194 pages
  • Therapy  

    Infectious Dise...  

    Eye Disease  

  • United Kingdom  

View report >

Opioid and Anesthetics Market in Australia

  • December 2016
    5 pages
  • Opioid  

    Anesthetics  

    Analgesic  

  • Australia  

View report >

Related Market Segments :

Opioid
Therapy
Pharmaceutical
Clinical Trial

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.